Nivolumab induced encephalopathy in a man with metastatic renal cell cancer: a case report
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1752-1947
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Nivolumab induced encephalopathy in a man with metastatic renal cell cancer: a case report ; volume:12 ; number:1 ; day:15 ; month:9 ; year:2018 ; pages:1-8 ; date:12.2018
Journal of medical case reports ; 12, Heft 1 (15.9.2018), 1-8, 12.2018
- Creator
-
Kopecký, Jindřich
- Contributor
-
Kubeček, Ondřej
Geryk, Tomáš
Slováčková, Birgita
Hoffmann, Petr
Žiaran, Miroslav
Priester, Peter
SpringerLink (Online service)
- DOI
-
10.1186/s13256-018-1786-9
- URN
-
urn:nbn:de:101:1-2018102023390950309993
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:37 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kopecký, Jindřich
- Kubeček, Ondřej
- Geryk, Tomáš
- Slováčková, Birgita
- Hoffmann, Petr
- Žiaran, Miroslav
- Priester, Peter
- SpringerLink (Online service)
Other Objects (12)
Immune-Related Meningoencephalitis following Nivolumab in Metastatic Renal Cell Carcinoma
Pazopanib after Nivolumab-Induced Tumor Lysis Syndrome in a Patient with Metastatic Clear-Cell Renal Cell Carcinoma
Nivolumab Induced Lethal Aplastic Anemia in a Patient with Metastatic Melanoma
Immunomodulatory response to neoadjuvant nivolumab in non-metastatic clear cell renal cell carcinoma
Nivolumab for Metastatic Cutaneous Squamous Cell Carcinoma
Metastatic Merkel cell carcinoma response to nivolumab
Nivolumab induced myxedema crisis
Pre-treatment metastatic growth rate is associated with clinical outcome in patients with metastatic renal cell carcinoma treated with nivolumab
Visceral Leishmaniasis in a 62-Year-Old Woman with Metastatic Renal Cancer in Treatment with Nivolumab
Significant response to nivolumab for metastatic chromophobe renal cell carcinoma with sarcomatoid differentiation: a case report
Prognostic impact of FAN score in patients receiving nivolumab plus ipilimumab for metastatic renal cell carcinoma
Nivolumab-Induced Exocrine Pancreatic Insufficiency
Immune-Related Meningoencephalitis following Nivolumab in Metastatic Renal Cell Carcinoma
Pazopanib after Nivolumab-Induced Tumor Lysis Syndrome in a Patient with Metastatic Clear-Cell Renal Cell Carcinoma
Nivolumab Induced Lethal Aplastic Anemia in a Patient with Metastatic Melanoma
Immunomodulatory response to neoadjuvant nivolumab in non-metastatic clear cell renal cell carcinoma
Nivolumab for Metastatic Cutaneous Squamous Cell Carcinoma
Metastatic Merkel cell carcinoma response to nivolumab
Nivolumab induced myxedema crisis
Pre-treatment metastatic growth rate is associated with clinical outcome in patients with metastatic renal cell carcinoma treated with nivolumab
Visceral Leishmaniasis in a 62-Year-Old Woman with Metastatic Renal Cancer in Treatment with Nivolumab
Significant response to nivolumab for metastatic chromophobe renal cell carcinoma with sarcomatoid differentiation: a case report
Prognostic impact of FAN score in patients receiving nivolumab plus ipilimumab for metastatic renal cell carcinoma
Nivolumab-Induced Exocrine Pancreatic Insufficiency
Immune-Related Meningoencephalitis following Nivolumab in Metastatic Renal Cell Carcinoma
Pazopanib after Nivolumab-Induced Tumor Lysis Syndrome in a Patient with Metastatic Clear-Cell Renal Cell Carcinoma
Nivolumab Induced Lethal Aplastic Anemia in a Patient with Metastatic Melanoma
Immunomodulatory response to neoadjuvant nivolumab in non-metastatic clear cell renal cell carcinoma
Nivolumab for Metastatic Cutaneous Squamous Cell Carcinoma
Metastatic Merkel cell carcinoma response to nivolumab
Nivolumab induced myxedema crisis
Pre-treatment metastatic growth rate is associated with clinical outcome in patients with metastatic renal cell carcinoma treated with nivolumab
Visceral Leishmaniasis in a 62-Year-Old Woman with Metastatic Renal Cancer in Treatment with Nivolumab
Significant response to nivolumab for metastatic chromophobe renal cell carcinoma with sarcomatoid differentiation: a case report
Prognostic impact of FAN score in patients receiving nivolumab plus ipilimumab for metastatic renal cell carcinoma